The Recall Desk
HighFDA (Drugs)·D-0533-2025·Announced 2025-07-23

[pending] RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)

Pending LLM rewrite. Source: FDA_DRUG D-0533-2025.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.

The recalled product

Product
RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
Brand
RIZATRIPTAN BENZOATE
Manufacturer
Ascend Laboratories, LLC

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (6)

  • Lot 23142117
  • 23142119
  • 23142122
  • Exp Date: May 2026
  • Lot 24142625
  • Exp Date: Jun. 2027

UPCs (1)

  • 0367877261300

Distribution

Distributed nationwide across the United States.